ERBB2 and breast carcinoma: The prognosis of locally advanced breast cancer (LABC)/metastatic breast cancer (MBC) depends heavily on patient and disease characteristics (e.g., tumor size, extent of lymph node involvement, sites of metastases, hormone receptor and human epidermal growth factor receptor 2 (HER2) status, and presence of an inflammatory component) [1, 2].